Hormonal
Ectopic expression of PPARγ in non-adipogenic fibroblasts induces adipocyte differentiation and triggers a cascade expression of cyclin-dependent kinase inhibitors p18(INK4c) and p21(Waf1/Cip1), thereby coupling growth arrest with terminal differentiation.
This research explains the molecular basis of why fat cells (adipocytes) are stable once formed. It shows that the formation of fat cells is not random but is driven by specific genetic switches (PPARγ) that turn off cell division (via p18 and p21). While this doesn't offer a direct 'hack' for weight loss, it underscores that adipose tissue is a metabolically active, genetically regulated organ, not just inert storage, and that its formation is a permanent structural change at the cellular level.
Ectopic expression of peroxisome proliferator-activated receptor (PPAR) g in non-precursor fibroblastic cell lines resulted in conversion to adipocytes and a coordinated increase in p18 and p21 mRNA and protein expression in a PPARg ligand-associated manner.
Why this rating
High-quality in vitro mechanistic study using stable cell lines and rigorous time-course analysis, though not a clinical trial.
Source
Role of PPARγ in Regulating a Cascade Expression of Cyclin-dependent Kinase Inhibitors, p18(INK4c) and p21(Waf1/Cip1), during Adipogenesis
Ron F. Morrison et al. · Journal of Biological Chemistry · 1999
DOI 10.1074/jbc.274.24.17088
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →